⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 5, 2016Journal of Clinical InvestigationOpen Access

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

Martina Absinta Pascal Sati Matthew K. Schindler Emily Leibovitch Joan Ohayon Tianxia Wu Alessandro Meani Massimo Filippi Steven Jacobson Irene Cortese Daniel S. Reich

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

The Intramural Research Program of NINDS supported this study.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Absinta et al. (2016) studied this question.

synapsesocial.com/papers/69d9d986a1d151c65f6853f9 https://doi.org/10.1172/jci86198

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelinationOriginal Research · 2000 · 3,350 citations
2Remyelination is extensive in a subset of multiple sclerosis patientsClinical Trial · 2006 · 807 citations
3Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosisRetrospective Study · 2008 · 864 citations
4Premyelinating Oligodendrocytes in Chronic Lesions of Multiple SclerosisOriginal Research · 2002 · 991 citations
5Enhancing remyelination in disease--can we wrap it up?Review · 2011 · 182 citations

The complex world of oligodendroglial differentiation inhibitors2011
The translational biology of remyelination: Past, present, and future2014
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque2015
Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation programJournal of Clinical Investigation · 2026
HIV reservoir cells do not show general resistance to effector molecules secreted by cytolytic T lymphocytesJournal of Clinical Investigation · 2026

More from Journal of Clinical Investigation

More from Vita-Salute San Raffaele University